Furthermore, its pro-apoptotic effects are often cell-type specific, and in some resistant tumor models, betulinic acid fails to induce strong caspase activation due to compensatory anti-apoptotic mechanisms such as upregulation of Bcl-2 or survival [77]. Here, BCL2 is linked to neoplasm.